Skip to main content
Access Resources

MJFF Publications

4651 - 4660 of 7407 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • RESTRICTED
    Title: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Cognitive Performance in Parkinson’s Disease in the Brain Health Registry
    Journal Name: Journal of Alzheimer's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jad-181009
    Citation Count: 7
  • OPEN
    Title: Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-09613-z
    Citation Count: 138
  • OPEN
    Title: Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27659
    Citation Count: 239
  • OPEN
    Title: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982
    Citation Count: 45
  • OPEN
    Title: Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2019.01.011
    Citation Count: 27
  • OPEN
    Title: The sncRNA Zoo: a repository for circulating small noncoding RNAs in animals
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/nar/gkz227
    Citation Count: 8
  • OPEN
    Title: A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.12.050
    Citation Count: 61
  • RESTRICTED
    Title: Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.01.015
    Best OA location URL:
    Citation Count: 12
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.